These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 33976444)

  • 1. Diagnostics for COVID-19: A case for field-deployable, rapid molecular tests for community surveillance.
    Frimpong M; Amoako YA; Anim KB; Ahor HS; Yeboah R; Arthur J; Dakorah JS; Gborgblovor D; Akrofi S; Sekyi-Djan P; Owusu M; Sylverken AA; Binger T; Phillips RO
    Ghana Med J; 2020 Dec; 54(4 Suppl):71-76. PubMed ID: 33976444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis for the novel coronavirus SARS-CoV-2: lessons learnt from the Ghana experience.
    Asante IA; Adusei-Poku M; Bonney HK; Bonney EY; Odoom JK; Obodai E; Aboagye J; Kotey EN; Nyarko S; Boatemaa L; Magnusen V; Lamptey H; Kyei GB; Ampofo WK
    Ghana Med J; 2020 Dec; 54(4 Suppl):77-85. PubMed ID: 33976445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, deployment and in-field demonstration of mobile coronavirus SARS-CoV-2 Nucleic acid amplification test.
    Paton TF; Marr I; O'Keefe Z; Inglis TJJ
    J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33856292
    [No Abstract]   [Full Text] [Related]  

  • 5. An Observational Laboratory-Based Assessment of SARS-CoV-2 Molecular Diagnostics in Benin, Western Africa.
    Sander AL; Yadouleton A; Moreira-Soto A; Tchibozo C; Hounkanrin G; Badou Y; Fischer C; Krause N; Akogbeto P; F de Oliveira Filho E; Dossou A; Brünink S; Drosten C; Aïssi MAJ; Harouna Djingarey M; Hounkpatin B; Nagel M; Drexler JF
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a web-based contact tracing and point-of-care-testing workflow for SARS-CoV-2 at a German University Hospital.
    Zirbes J; Sterr CM; Steller M; Dapper L; Nonnenmacher-Winter C; Günther F
    Antimicrob Resist Infect Control; 2021 Jul; 10(1):102. PubMed ID: 34215330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic.
    Xing W; Wang J; Zhao C; Wang H; Bai L; Pan L; Li H; Wang H; Zhang Z; Lu Y; Chen X; Shan S; Wang D; Pan Y; Weng D; Zhou X; Huang R; He J; Jin R; Li W; Shang H; Zhong N; Cheng J
    Clin Chem; 2021 Mar; 67(4):672-683. PubMed ID: 33788940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory-Generated DNA Can Cause Anomalous Pathogen Diagnostic Test Results.
    Robinson-McCarthy LR; Mijalis AJ; Filsinger GT; de Puig H; Donghia NM; Schaus TE; Rasmussen RA; Ferreira R; Lunshof JE; Chao G; Ter-Ovanesyan D; Dodd O; Kuru E; Sesay AM; Rainbow J; Pawlowski AC; Wannier TM; Angenent-Mari NM; Najjar D; Yin P; Ingber DE; Tam JM; Church GM
    Microbiol Spectr; 2021 Oct; 9(2):e0031321. PubMed ID: 34523989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid COVID-19 Molecular Diagnostic System Using Virus Enrichment Platform.
    Jang YO; Lee HJ; Koo B; Cha HH; Kwon JS; Kim JY; Kim MG; Kim HS; Kim SH; Shin Y
    Biosensors (Basel); 2021 Oct; 11(10):. PubMed ID: 34677329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass testing after a single suspected or confirmed case of COVID-19 in London care homes, April-May 2020: implications for policy and practice.
    Tang S; Sanchez Perez M; Saavedra-Campos M; Paranthaman K; Myers R; Fok J; Crawley-Boevey E; Dun-Campbell K; Janarthanan R; Fernandez E; Vusirikala A; Patel B; Ma T; Amin-Chowdhury Z; Shetty N; Zambon M; Bell A; Wynne-Evans E; Chow Y; Ladhani S
    Age Ageing; 2021 May; 50(3):649-656. PubMed ID: 33620453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
    Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
    Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers.
    Mostafa A; Kandil S; El-Sayed MH; Girgis S; Hafez H; Yosef M; Saber S; Ezzelarab H; Ramadan M; Afifi I; Hassan F; Elsayed S; Reda A; Fattuh D; Mahmoud A; Mansour A; Sabry M; Habeb P; Ebeid FS; Saleh A; Mansour O; Omar A; El-Meteini M
    Int J Epidemiol; 2021 Mar; 50(1):50-61. PubMed ID: 33094320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of six nucleic acid amplification kits for SARS-CoV-2 RNA detection.
    Wu S; Shi X; Chen Q; Jiang Y; Zuo L; Wang L; Jiang M; Lin Y; Fang S; Peng B; Wu W; Liu H; Zhang R; Kwan PSL; Hu Q
    Ann Clin Microbiol Antimicrob; 2021 May; 20(1):38. PubMed ID: 34022903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19.
    Vatankhah M; Azizi A; Sanajouyan Langeroudi A; Ataei Azimi S; Khorsand I; Kerachian MA; Motaei J
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):225-241. PubMed ID: 33245685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update on Molecular Diagnostics for COVID-19.
    Islam KU; Iqbal J
    Front Cell Infect Microbiol; 2020; 10():560616. PubMed ID: 33244462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mobile DNA laboratory for forensic science adapted to coronavirus SARS-CoV-2 diagnosis.
    Touron P; Siatka C; Pussiau A; Follot S; Fritz T; Petit M; Latifa N; Herrmann JL; Rottman M; Lemoine A; Hubac S
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):197-200. PubMed ID: 32666482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study.
    Grassly NC; Pons-Salort M; Parker EPK; White PJ; Ferguson NM;
    Lancet Infect Dis; 2020 Dec; 20(12):1381-1389. PubMed ID: 32822577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mirror Technology Facilitates High-Throughput, Accurate SARS-CoV-2 Testing.
    Realegeno S; Hash S; Wong C; Liu R; Shepherd J; Schooley RT; Lipson DA; Fung F; Menon S; Pride DT
    Microbiol Spectr; 2021 Sep; 9(1):e0039221. PubMed ID: 34431687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.
    Desai KT; Alfaro K; Mendoza L; Faron M; Mesich B; Maza M; Dominguez R; Valenzuela A; Acosta CD; Martínez M; Felix JC; Masch R; Smith JS; Gabrilovich S; Wu T; Plump M; Novetsky AP; Einstein MH; Douglas NC; Cremer M; Wentzensen N
    Microbiol Spectr; 2021 Oct; 9(2):e0084621. PubMed ID: 34668736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.